Negative Pressure Wound Therapy (NPWT) Market By Product (Conventional/Traditional, Single-use, Accessories), Wound Type (Diabetic Foot Ulcer [DFU], Venous Leg Ulcer, Surgical, Burn, Skin Grafts), End User (Hospital, Home Care)

Description

List of Tables

Negative Pressure Wound Therapy (NPWT) Market Size, Share, Forecast, & Trends Analysis by Product (Conventional/Traditional, Single-use, Accessories), Wound Type (Diabetic Foot Ulcer, Venous Leg Ulcer, Surgical, Burn), End User - Global Forecast to 2030

The negative pressure wound therapy market is projected to reach $4.04 billion by 2030, at a CAGR of 6% from 2023 to 2030.

Following comprehensive primary and secondary research and an in-depth analysis of the market scenario, this report provides an analysis of the key market drivers, restraints, opportunities, and challenges. This market is driven by the increasing prevalence of diabetes and chronic wounds, the rising elderly population, favorable reimbursement policies, and the increasing incidence of obesity and associated comorbidities. However, the high costs of NPWT devices and the risk of complications with the use of NPWT devices restrain the growth of this market.

Furthermore, technological advancements in negative pressure wound therapy devices and emerging economies are expected to provide growth opportunities for the players in this market. However, healthcare professionals' limited awareness and training and patients' lack of adherence to treatment due to discomfort are major challenges impacting market growth.

Based on product, in 2023, the conventional/traditional NPWT devices segment is expected to account for the largest share of the negative pressure wound therapy market. Conventional NPWT devices typically consist of a vacuum pump, tubing, and dressing materials, which create negative pressure or suction at the wound site to facilitate healing. Factors such as the widespread use of NPWT devices in hospitals for the treatment of various types of wounds, proven clinical outcomes, and the high preference for conventional NPWT devices among healthcare professionals contribute to the large market share of this segment.

By wound type, in 2023, the diabetic foot ulcers segment is expected to account for the largest share of the negative pressure wound therapy market. The large market share of this segment is attributed to the increased prevalence of diabetes and associated diabetic foot ulcers, rising awareness among patients, and proven clinical outcomes of NPWT devices in treating diabetic foot ulcers.

Based on end user, in 2023, the hospital & clinics segment is expected to account for the largest share of the negative pressure wound therapy market. The large market share of this segment is attributed to the increased adoption of NPWT in hospitals, high awareness about the benefits of NPWT among healthcare professionals, and the rising patient population.

An in-depth analysis of the geographical scenario in the negative pressure wound therapy market provides detailed qualitative and quantitative insights into five major geographies (North America, Europe, Asia-Pacific, the Middle East & Africa, and Latin America) along with the coverage of major countries in each region.

In 2023, North America is expected to account for the largest share of the negative pressure wound therapy market, followed by Europe and Asia-Pacific. North America's large market share is attributed to the region's advanced healthcare infrastructure, the presence of key market players, and high awareness regarding the benefits of NPWT in chronic wound management.

The key players operating in the negative pressure wound therapy market are Acelity L.P. Inc. (U.S.), Cardinal Health, Inc. (U.S.), Convatec Group plc (U.S.), DeRoyal Industries, Inc. (U.S.), Genadyne Biotechnologies, Inc. (U.S.), Medela AG (Switzerland), Molnlycke Health Care AB (Sweden), Smith & Nephew plc (U.K.), PAUL HARTMANN AG (Germany), and Talley Group Ltd (U.K.).

Scope of the Report:

Negative Pressure Wound Therapy Market-by Product

Conventional/Traditional NPWT Devices
Single-use NPWT Devices
Accessories & Consumables

Negative Pressure Wound Therapy Market-by Wound Type

Diabetic Foot Ulcers
Venous Leg Ulcers
Surgical Wounds
Skin Grafts
Burn Wounds
Other Wound Types

Note: Other wound types include pressure ulcers, wounds from infections, and traumatic wounds.

Negative Pressure Wound Therapy Market-by End User

Hospitals & Clinics
Home Care Settings
Other End Users

Note: Other end users primarily include long-term care facilities, ambulatory surgical centers, and rehabilitation centers.

Negative Pressure Wound Therapy Market-by Geography

North America
- U.S.
- Canada
Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe (RoE)
Asia-Pacific (APAC)
- China
- Japan
- India
- Rest of Asia-Pacific (RoAPAC)
Latin America
Middle East & Africa

Product Code: MRHC - 104852

1. Market Definition & Scope

1.1. Market Definition
1.2. Market Ecosystem
1.3. Currency
1.4. Key Stakeholders

2. Research Methodology

2.1. Research Approach
2.2. Process of Data Collection & Validation
- 2.2.1. Secondary Research
- 2.2.2. Primary Research/Interviews with Key Opinion Leaders of the Industry
2.3. Market Sizing and Forecast
- 2.3.1. Market Size Estimation Approach
- 2.3.2. Growth Forecast Approach
- 2.3.3. Market Share Analysis
2.4. Assumptions for this Study

3. Executive Summary

4. Market Insights

4.1. Market Overview
4.2. Drivers
- 4.2.1. Increasing Prevalence of Diabetes and Chronic Wounds
- 4.2.2. Rising Elderly Population
- 4.2.3. Favorable Reimbursement Policies
- 4.2.4. Increasing Incidence of Obesity and Associated Comorbidities
4.3. Restraints
- 4.3.1. High Costs of NPWT Devices
- 4.3.2. Potential Risk of Complications
4.4. Opportunity
- 4.4.1. Technological Advancements in Negative Pressure Wound Therapy Devices
- 4.4.2 Emerging Economies
4.5. Challenges
- 4.5.1. Limited Awareness and Training Among Healthcare Professionals
- 4.5.2. Lack of Adherence to the Treatment Among Patients Due to Discomfort
4.6. Pricing Analysis
4.7. Regulatory Analysis
4.8. Industry & Technological Trends

5. Negative Pressure Wound Therapy Market Assessment-by Product

5.1. Overview
5.2. Conventional/Traditional NPWT Devices
5.3. Single-use NPWT Devices
5.4. Accessories & Consumables

6. Negative Pressure Wound Therapy Market Assessment-by Wound Type

6.1. Overview
6.2. Diabetic Foot Ulcers
6.3. Venous Leg Ulcers
6.4. Surgical Wounds
6.5. Skin Grafts
6.6. Burn Wounds
6.7. Other Wound Types

7. Negative Pressure Wound Therapy Market Assessment-by End User

7.1. Overview
7.2. Hospitals & Clinics
7.3. Home Care Settings
7.4. Other End Users

8. Negative Pressure Wound Therapy Market Assessment-by Geography

8.1. Overview
8.2. North America
- 8.2.1. U.S.
- 8.2.2. Canada
8.3. Europe
- 8.3.1. Germany
- 8.3.2. U.K.
- 8.3.3. France
- 8.3.4. Italy
- 8.3.5. Spain
- 8.3.6. Rest of Europe
8.4. Asia-Pacific
- 8.4.1. China
- 8.4.2. Japan
- 8.4.3. India
- 8.4.4. Rest of Asia-Pacific
8.5. Latin America
8.6. Middle East & Africa

9. Competition Analysis

9.1. Overview
9.2. Key Growth Strategies
9.3. Vendor Benchmarking
9.4. Competitive Dashboard
- 9.4.1. Industry Leaders
- 9.4.2. Market Differentiators
- 9.4.3. Vanguards
- 9.4.4. Emerging Companies
9.5. Market Share Analysis (2022)

10. Company Profiles (Company Overview, Financial Overview, Product Portfolio, Strategic Developments, and SWOT Analysis of Top 5 Companies)

10.1. Acelity L.P. Inc.
10.2. Cardinal Health, Inc.
10.3. Convatec Group plc
10.4. DeRoyal Industries, Inc.
10.5. Genadyne Biotechnologies, Inc.
10.6. Medela AG
10.7. Molnlycke Health Care AB
10.8. Smith & Nephew plc
10.9. PAUL HARTMANN AG
10.10. Talley Group Ltd
10.11. Other Companies

11. Appendix

11.1. Available Customization
11.2. Related Reports